256 related articles for article (PubMed ID: 6318777)
1. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
[TBL] [Abstract][Full Text] [Related]
2. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
[TBL] [Abstract][Full Text] [Related]
3. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
4. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
[TBL] [Abstract][Full Text] [Related]
5. C1 activation and dissociation in disease.
Laurell AB; Mårtensson U; Sjöholm AG
Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
7. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.
Oleesky DA; Daniels RH; Williams BD; Amos N; Morgan BP
Clin Exp Immunol; 1991 May; 84(2):250-5. PubMed ID: 2025952
[TBL] [Abstract][Full Text] [Related]
8. FN-C1q and C1 INH C1r-C1s complexes as indicators of complement activation in patients with chronic lymphocytic leukaemia.
Hidvégi T; Ermolin GA; Efremov EE; Dikov MM; Kurmanova LV; Vnashenkova GV; Merkulova MV; Kókai M; Panya A; Füst G
Immunol Lett; 1989 Jul; 22(1):1-6. PubMed ID: 2550362
[TBL] [Abstract][Full Text] [Related]
9. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
10. The role of immune complexes in the activation of the first component of human complement.
Ziccardi RJ
J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
[TBL] [Abstract][Full Text] [Related]
11. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
[TBL] [Abstract][Full Text] [Related]
12. A molecular mechanism for the activation of the first component of complement by immune complexes.
Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
[TBL] [Abstract][Full Text] [Related]
13. Complement components, C1 activation and disease activity in SLE.
Sturfelt G; Sjöholm AG; Svensson B
Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
[TBL] [Abstract][Full Text] [Related]
14. The first component of human complement (C1): activation and control.
Ziccardi RJ
Springer Semin Immunopathol; 1983; 6(2-3):213-30. PubMed ID: 6314572
[TBL] [Abstract][Full Text] [Related]
15. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease.
Melsom RD; Horsfall AC; Schrieber L; Charles P; Maini RN
Rheumatol Int; 1986; 6(5):227-31. PubMed ID: 3492027
[TBL] [Abstract][Full Text] [Related]
17. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
Bauer J; Valet G
Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
[TBL] [Abstract][Full Text] [Related]
18. Activation of the first component of complement.
Schumaker VN; Zavodszky P; Poon PH
Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
[No Abstract] [Full Text] [Related]
19. Trimer and tetramer complexes containing C1 esterase inhibitor, C1r and C1s, in serum and synovial fluid of patients with rheumatic disease.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol Methods; 1990 May; 129(1):55-61. PubMed ID: 2338498
[TBL] [Abstract][Full Text] [Related]
20. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]